EUVIMEDEUVIMED entdecken
Vergleichsstudie

Efficacy and safety of spironolactone versus bicalutamide in female pattern hair loss: A retrospective comparative study

Abhijeet Kumar Jha iD, M D Zeeshan iD, Anupama Singh iD, Anil Kumar Singh

Australasian Journal of Dermatology · 2024

DOI: 10.1111/ajd.14306 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Australasian Journal of Dermatology, 2024. Verfasst von Abhijeet Kumar Jha und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology & STD, Patna Medical College & Hospital, Patna, India. Hauptthemen laut MEDLINE: Spironolactone, Anilides, Alopecia, Tosyl Compounds. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 16 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Female‐pattern hair loss (FPHL) is characterized by decreased scalp hair density, thinning of hair shafts, and progressive miniaturization of hair follicles.

Objective

To compare the safety and efficacy of spironolactone versus bicalutamide in female pattern hair loss [FPHL].

Methods

The study design was retrospective, and all eligible females aged between 18 years and 50 years with FPHL were included. We identified 120 patients from our database who fulfilled the inclusion and exclusion criteria, and patients were then categorized into two groups, Group A comprising patients who were taking 100 mg of spironolactone once daily and Group B comprising patients who were taking 50 mg of bicalutamide once daily along with topical minoxidil 2% in both groups. Patient were analysed at approximately at 24 weeks from the commencement of the treatment.

Results

Mean reduction in hair loss severity score on Sinclair scale was 19.51% in spironolactone group compared to 28.20% in bicalutamide group at 24 weeks, which was statistically significant. On global photographic assessment, marked improvement was seen in bicalutamide group compared to spironolactone group ( p = 0.139).

Conclusions

Our study, though limited by its retrospective design and small sample size, showed that bicalutamide has greater efficacy and better safety profile in comparison to spironolactone in the treatment of FPHL.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SpironolactoneAnilidesAlopeciaTosyl CompoundsNitrilesHumansFemaleRetrospective StudiesAdultMiddle AgedYoung AdultMinoxidilTreatment OutcomeAdolescentSeverity of Illness Index

Stichwörter der Autor:innen

dermoscopyfemale pattern losshairhair dermatoscopy

Substanzen

SpironolactoneAnilidesbicalutamideTosyl CompoundsNitrilesMinoxidil

Autor:innen und Institutionen

  • Department of Dermatology & STD, Patna Medical College & Hospital, Patna, India.
  • Endocrinology Clinic Srikrishna Puri, Patna, India.

ORCID-Profile: Abhijeet Kumar Jha, M D Zeeshan, Anupama Singh

Zitieren

APA

Jha, A. K., Zeeshan, M. D., Singh, A., & Singh, A. K. (2024). Efficacy and safety of spironolactone versus bicalutamide in female pattern hair loss: A retrospective comparative study. Australasian Journal of Dermatology. https://doi.org/10.1111/ajd.14306

Vancouver

Jha AK, Zeeshan MD, Singh A, Singh AK. Efficacy and safety of spironolactone versus bicalutamide in female pattern hair loss: A retrospective comparative study. Australasian Journal of Dermatology. 2024. doi:10.1111/ajd.14306

BibTeX
@article{Jha2024,
  author = {Jha, Abhijeet Kumar and Zeeshan, M D and Singh, Anupama and Singh, Anil Kumar},
  title = {Efficacy and safety of spironolactone versus bicalutamide in female pattern hair loss: A retrospective comparative study},
  journal = {Australasian Journal of Dermatology},
  year = {2024},
  doi = {10.1111/ajd.14306}
}
Kostenlos starten →